We are live on ! Find out more
BCB

Brian C. Broderick Portfolio holdings

AUM $542M
1-Year Est. Return 20.28%
This Fund
S&P 500
This Quarter Est. Return
-12.6%
1 Year Est. Return
+20.28%
3 Year Est. Return
+64.8%
5 Year Est. Return
+86.99%
10 Year Est. Return
+301.53%
AUM
$330M
AUM Growth
-$61.7M
Cap. Flow
-$2.47M
Cap. Flow %
-0.75%
Top 10 Hldgs %
39.97%
Holding
75
New
–
Increased
15
Reduced
37
Closed
4

Top Buys

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$814K
2
NKE icon
Nike
NKE
+$323K
3
NVDA icon
NVIDIA
NVDA
+$255K
4
HON icon
Honeywell
HON
+$175K
5
ROK icon
Rockwell Automation
ROK
+$144K

Top Sells

Rank Stock Value
1
UL icon
Unilever
UL
+$882K
2
BDX icon
Becton Dickinson
BDX
+$339K
3
NVS icon
Novartis
NVS
+$338K
4
ABBV icon
AbbVie
ABBV
+$317K
5
INTC icon
Intel
INTC
+$259K

Sector Composition

Rank Sector Weight
1 Healthcare 23.32%
2 Technology 23.27%
3 Industrials 13.2%
4 Consumer Discretionary 7.94%
5 Consumer Staples 6.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NKE icon
26
Nike
NKE
$64.5B
$4M 1.21%
39,160
+2,730
+7% +$323K
EW icon
27
Edwards Lifesciences
EW
$48.9B
$3.99M 1.21%
42,003
+520
+1% +$53.8K
PEP icon
28
PepsiCo
PEP
$185B
$3.98M 1.21%
23,875
-70
-0.3% -$11.8K
CVX icon
29
Chevron
CVX
$378B
$3.8M 1.15%
26,238
-1,337
-5% -$221K
PYPL icon
30
PayPal
PYPL
$50.1B
$3.78M 1.15%
54,130
+1,114
+2% +$96.6K
XOM icon
31
ExxonMobil
XOM
$615B
$3.07M 0.93%
35,889
-285
-0.8% -$25.7K
ILMN icon
32
Illumina
ILMN
$27.9B
$2.81M 0.85%
15,689
-19
-0.1% -$4.85K
NVS icon
33
Novartis
NVS
$285B
$2.74M 0.83%
32,385
-3,848
-11% -$338K
CHD icon
34
Church & Dwight Co
CHD
$23.2B
$2.58M 0.78%
27,893
-65
-0.2% -$6.14K
MDT icon
35
Medtronic
MDT
$107B
$2.51M 0.76%
28,005
+8,036
+40% +$814K
ABBV icon
36
AbbVie
ABBV
$448B
$2.03M 0.62%
13,237
-2,075
-14% -$317K
APTV icon
37
Aptiv
APTV
$12.1B
$1.84M 0.56%
20,627
+1,197
+6% +$122K
SPTM icon
38
State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF
SPTM
$13.5B
$1.39M 0.42%
30,000
– –
WELL icon
39
Welltower
WELL
$173B
$1.24M 0.37%
15,000
– –
IRWD icon
40
Ironwood Pharmaceuticals
IRWD
$634M
$963K 0.29%
83,500
-12,500
-13% -$147K
BMY icon
41
Bristol-Myers Squibb
BMY
$123B
$901K 0.27%
11,700
– –
MMM icon
42
3M
MMM
$83B
$899K 0.27%
8,306
-299
-3% -$36.1K
INTC icon
43
Intel
INTC
$488B
$822K 0.25%
21,990
-5,975
-21% -$259K
BDX icon
44
Becton Dickinson
BDX
$42.6B
$805K 0.24%
3,266
-1,337
-29% -$339K
PBA icon
45
Pembina Pipeline
PBA
$29.5B
$788K 0.24%
22,300
-128
-0.6% -$4.93K
UNP icon
46
Union Pacific
UNP
$176B
$594K 0.18%
2,789
-5
-0.2% -$1.14K
TMO icon
47
Thermo Fisher Scientific
TMO
$196B
$584K 0.18%
1,075
– –
NVO
48
Novo Nordisk
NVO
$219B
$524K 0.16%
9,400
-200
-2% -$11.1K
MRK icon
49
Merck
MRK
$307B
$516K 0.16%
5,650
– –
TT icon
50
Trane Technologies
TT
$103B
$516K 0.16%
3,970
– –
1
2
3

Similar funds

MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
GPWA
Great Point Wealth Advisors Boston, Massachusetts $542M AUM
WCA
Westover Capital Advisors Wilmington, Delaware $543M AUM 36.85% 1-Year Est. Return
ISB
Iowa State Bank Urbandale, Iowa $543M AUM 21.44% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $541M AUM 1,009.51% 1-Year Est. Return
FMC
FTV Management Company San Francisco, California $541M AUM 34.37% 1-Year Est. Return
HCM
Hutchinson Capital Management San Rafael, California $544M AUM 9.54% 1-Year Est. Return
FSA
Financial Security Advisor Virginia Beach, Virginia $544M AUM 18.82% 1-Year Est. Return

Brian C. Broderick's Q2 2022 Portfolio in Review

As of Q2 2022, Brian C. Broderick held 75 positions worth $330M, down 16% from $391M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Brian C. Broderick's Q2 2022 filing shows 15 increased, 37 reduced and 4 closed positions. The largest sale was Unilever, an estimated $882K.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 22% a quarter earlier, followed by Technology and Industrials.

  • Brian C. Broderick added most to Medtronic in Q2 2022, an estimated $814K increase.
  • Brian C. Broderick's biggest Q2 2022 reduction was Becton Dickinson, cutting an estimated $339K.
  • Brian C. Broderick fully exited Unilever in Q2 2022, selling an estimated $882K.
  • Brian C. Broderick's ten largest holdings make up 40% of its $330M portfolio in Q2 2022.
  • Brian C. Broderick opened 0 new positions and closed 4 in Q2 2022.
  • Brian C. Broderick's portfolio value fell 16% quarter-over-quarter to $330M.

Based on Brian C. Broderick's 13F filing for Q2 2022, filed 19 Jul 2022.